Authors: Sophia Hessami
Mentors: Elizabeth Vargis
Insitution: Utah State University
Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries. During later stages of AMD, immature blood vessels penetrate Bruch’s membrane and release fluid into the subretinal space. This process is referred to as choroidal neovascularization (CNV). Current in vitro models of retinal tissue are limited, so we propose a three-layered microfluidic model of the subretinal tissue, consisting of retinal pigment epithelium (RPE), Bruch’s membrane (BrM), and choroid. We have produced models of BrM using hagfish proteins that are more mimetic to the nonporous, proteinaceous BrM that is seen in vivo. Then, we fabricated a three-layered microfluidic device using the BrM models and polydimethylsiloxane (PDMS). Once the devices were assembled, porcine primary RPE were isolated, cultured, and characterized in the upper channel of the microfluidic device. Going forward, HUVECs will be cultured and characterized in the lower channel of the device. Then, primary RPE and HUVECs will be co-cultured and characterized within the device. The result will be a multilayered microfluidic device containing primary porcine RPE, hagfish protein BrM models, and human umbilical vein endothelial cell (HUVEC) choroid. It is expected that RPE protein secretions will diffuse through the BrM models and initiate interconnected vascular network formation in the endothelial cells. In the future, we will induce chemical hypoxia to turn this model into a diseased model of the subretina. We hypothesize that this in vitro model of the subretinal tissue will lead to a better understanding of the mechanisms of CNV initiation and progression in AMD.